We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
-0.4%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.27B
AUM Growth
–
Cap. Flow
+$1.29B
Cap. Flow %
101.89%
Top 10 Hldgs %
12.2%
Holding
422
New
422
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$18.9M
2
AGN
Allergan Inc
AGN
+$18.6M
3
PFE icon
Pfizer
PFE
+$18.6M
4
WDC icon
Western Digital
WDC
+$15.4M
5
SHPG
Shire pic
SHPG
+$15.3M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 13.26%
2 Consumer Discretionary 12.33%
3 Technology 11.82%
4 Industrials 10.72%
5 Financials 9.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BSBR icon
301
Santander
BSBR
$43.4B
$539K 0.04%
+90,401
New +$611K
CPWR
302
DELISTED
COMPUWARE CORP
CPWR
$538K 0.04%
+54,155
New +$591K
XME icon
303
State Street SPDR S&P Metals & Mining ETF
XME
$4.22B
$532K 0.04%
+16,057
New +$590K
LBTYK icon
304
Liberty Global Class C
LBTYK
$3.58B
$531K 0.04%
+19,350
New +$542K
CNS icon
305
Cohen & Steers
CNS
$4.34B
$528K 0.04%
+15,538
New +$590K
MON
306
DELISTED
Monsanto Co
MON
$527K 0.04%
+5,333
New +$558K
HAE icon
307
Haemonetics
HAE
$3.86B
$524K 0.04%
+12,663
New +$513K
SQM icon
308
Sociedad Química y Minera de Chile
SQM
$20.7B
$516K 0.04%
+13,112
New +$607K
FHI icon
309
Federated Hermes
FHI
$4.72B
$514K 0.04%
+18,770
New +$476K
GPOR
310
DELISTED
Gulfport Energy Corp.
GPOR
$512K 0.04%
+10,871
New +$532K
QCOR
311
DELISTED
QUESTCOR PHARMA INC
QCOR
$512K 0.04%
+11,263
New +$400K
IN
312
DELISTED
INTERMEC, INC.
IN
$510K 0.04%
+51,923
New +$510K
FOE
313
DELISTED
Ferro Corporation
FOE
$506K 0.04%
+72,822
New +$506K
SSNC icon
314
SS&C Technologies
SSNC
$18.7B
$503K 0.04%
+30,566
New +$476K
SHW icon
315
Sherwin-Williams
SHW
$88.2B
$502K 0.04%
+8,535
New +$515K
SONC
316
DELISTED
Sonic Corp
SONC
$493K 0.04%
+33,879
New +$451K
CYNO
317
DELISTED
Cynosure, Inc. Class A
CYNO
$492K 0.04%
+18,954
New +$475K
BEAM
318
DELISTED
BEAM INC COM STK (DE)
BEAM
$488K 0.04%
+7,734
New +$501K
JAH
319
DELISTED
JARDEN CORPORATION
JAH
$485K 0.04%
+16,635
New +$499K
PAY
320
DELISTED
Verifone Systems Inc
PAY
$478K 0.04%
+28,407
New +$579K
CW icon
321
Curtiss-Wright
CW
$26.4B
$475K 0.04%
+12,830
New +$445K
AZPN
322
DELISTED
ASPEN TECHNOLOGY INC
AZPN
$473K 0.04%
+16,434
New +$473K
PVH icon
323
PVH
PVH
$3.99B
$470K 0.04%
+3,760
New +$431K
ATML
324
DELISTED
ATMEL CORP
ATML
$465K 0.04%
+63,304
New +$447K
COR
325
DELISTED
Coresite Realty Corporation
COR
$462K 0.04%
+14,519
New +$496K
11 12
13
14 15

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Marshall Wace North America, which disclosed 422 positions worth $1.27B. Its ten largest holdings account for 12% of the portfolio.

Its largest position is Eli Lilly: 347,198 shares worth $17.1M.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, followed by Consumer Discretionary and Technology.

  • Marshall Wace North America's largest Q2 2013 buy was Eli Lilly: 347,198 shares worth $17.1M.
  • Marshall Wace North America's ten largest holdings make up 12% of its $1.27B portfolio in Q2 2013.
  • Marshall Wace North America disclosed 422 positions in Q2 2013, its first 13F filing on record.

Based on Marshall Wace North America's 13F filing for Q2 2013, filed 6 Aug 2013.